Contact this trialFirst, we need to learn more about you.
Sphingosine-1-phosphate receptor modulator
Amiselimod (MT-1303) for Colitis
Recruiting0 awardsPhase 2
Miramar, Florida
This trial will study a new drug for ulcerative colitis, to see if it is better than placebo and can be used for long-term treatment.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service